Neuronetics, Inc. (STIM) stock
STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.28+0.03 (+2.40%)
Close on Nov 17, 2026Market cap $97.53MP/E –Yield –
Neuronetics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Neuronetics's profit margin for the twelve months ending Jun 30, 2026 was -19.6%. For fiscal 2025 it was -26.1%, against -58.4% the year before. The highest annual figure on record is -26.1% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -26.1% | +32.2 |
| FY2024 | Dec 31, 2024 | -58.4% | −16.1 |
| FY2023 | Dec 31, 2023 | -42.3% | +14.7 |
| FY2022 | Dec 31, 2022 | -57.0% | −0.6 |
| FY2021 | Dec 31, 2021 | -56.4% | −0.6 |
| FY2020 | Dec 31, 2020 | -55.7% | −9.4 |
| FY2019 | Dec 31, 2019 | -46.4% | −0.7 |
| FY2018 | Dec 31, 2018 | -45.7% | −5.9 |
| FY2017 | Dec 31, 2017 | -39.7% | −6.9 |
| FY2016 | Dec 31, 2016 | -32.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -8.3% | +18.3 |
| Q1 FY2026 | Mar 31, 2026 | -31.3% | +8.3 |
| Q4 FY2025 | Dec 31, 2025 | -17.1% | +39.2 |
| Q3 FY2025 | Sep 30, 2025 | -24.3% | +47.7 |
| Q2 FY2025 | Jun 30, 2025 | -26.6% | +33.2 |
| Q1 FY2025 | Mar 31, 2025 | -39.6% | +5.6 |
| Q4 FY2024 | Dec 31, 2024 | -56.3% | −29.8 |
| Q3 FY2024 | Sep 30, 2024 | -72.0% | −19.5 |
| Q2 FY2024 | Jun 30, 2024 | -59.8% | −31.9 |
| Q1 FY2024 | Mar 31, 2024 | -45.2% | +22.5 |
| Q4 FY2023 | Dec 31, 2023 | -26.5% | +19.1 |
| Q3 FY2023 | Sep 30, 2023 | -52.5% | −6.4 |
| Q2 FY2023 | Jun 30, 2023 | -27.8% | +36.0 |
| Q1 FY2023 | Mar 31, 2023 | -67.7% | +8.7 |
| Q4 FY2022 | Dec 31, 2022 | -45.6% | +5.3 |
| Q3 FY2022 | Sep 30, 2022 | -46.1% | +12.9 |
| Q2 FY2022 | Jun 30, 2022 | -63.8% | −10.8 |
| Q1 FY2022 | Mar 31, 2022 | -76.4% | −12.3 |
| Q4 FY2021 | Dec 31, 2021 | -50.8% | −27.4 |
| Q3 FY2021 | Sep 30, 2021 | -59.1% | −31.6 |
| Q2 FY2021 | Jun 30, 2021 | -53.0% | +26.7 |
| Q1 FY2021 | Mar 31, 2021 | -64.1% | +45.8 |
| Q4 FY2020 | Dec 31, 2020 | -23.5% | +20.0 |
| Q3 FY2020 | Sep 30, 2020 | -27.5% | +15.5 |
| Q2 FY2020 | Jun 30, 2020 | -79.7% | −36.9 |
| Q1 FY2020 | Mar 31, 2020 | -109.9% | −50.8 |
| Q4 FY2019 | Dec 31, 2019 | -43.5% | −4.2 |
| Q3 FY2019 | Sep 30, 2019 | -42.9% | −6.8 |
| Q2 FY2019 | Jun 30, 2019 | -42.8% | +13.8 |
| Q1 FY2019 | Mar 31, 2019 | -59.2% | −5.0 |
| Q4 FY2018 | Dec 31, 2018 | -39.3% | +1.4 |
| Q3 FY2018 | Sep 30, 2018 | -36.1% | −0.3 |
| Q2 FY2018 | Jun 30, 2018 | -56.6% | −28.7 |
| Q1 FY2018 | Mar 31, 2018 | -54.1% | +5.8 |
| Q4 FY2017 | Dec 31, 2017 | -40.7% | – |
| Q3 FY2017 | Sep 30, 2017 | -35.8% | – |
| Q2 FY2017 | Jun 30, 2017 | -27.8% | – |
| Q1 FY2017 | Mar 31, 2017 | -60.0% | – |
See a number that looks wrong?